Trade Insight
    • Congress Trade
    • Insider Trade
    • Latest Trade
    • Congress Members
    • Corporate Insiders
More
  • TradeInsight.info LogoTradeInsight.info
    • FeaturesPricing
  • Sign InTry for Free
TradeInsight.info logo
TradeInsight.info
Formerly PelosiTrade.com
Operational
LinkedInGithubDiscord

Disclosures

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Product Updates

Knowledge

  • FAQ
  • Comparison guide
  • Security

Connect

  • About us
  • Contact
  • Careers

©2023-2025 TradeInsight.info. All rights reserved.

  • The content on this website is not intended as financial advice. Due diligence is required.
  • The date or time indicated here is given according to the US Eastern Time Zone.
  • The listed price is in USD and refers to the closing price on the specified trade date, before any adjustments due to stock splits or mergers, unless otherwise specified.
  • The Estimated Amount from Congress Trade is the midpoint of the trade value range from the report.
Cookie Notice

We use cookies to enhance your browsing experience.

Cookie Policy
  • 1/2
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.
Forgot your password?
Insider NameBuy/SellCompany NameTickerAmountShares Change
Dec 20, 2024Dec 27, 2024Redmile Group, LLC
Dir
10%
SellFate Therapeutics IncFATE$1.68$573,943-2.58%
Dec 11, 2024Dec 14, 2024Redmile Group, LLC
10%
BuyAdc Therapeutics SaADCT$3.05$609,000+0.69%
Dec 04, 2024Dec 07, 2024Redmile Group, LLC
10%
SellAdc Therapeutics SaADCT$2.07$52,479-0.09%
Dec 04, 2024Dec 07, 2024Redmile Group, LLC
Dir
10%
SellShattuck Labs, Inc.STTK$1.25$166,714-2.35%
Jul 01, 2024Jul 04, 2024Redmile Group, LLC
10%
BuyAdc Therapeutics SaADCT$2.81$2M+2.72%
Mar 01, 2024Mar 06, 2024Redmile Group, LLC
Dir
BuyAbsci CorpABSI$4.5$999,999+2.62%
Dec 26, 2023Dec 29, 2023Redmile Group, LLC
Dir
10%
BuyFate Therapeutics IncFATE$3.72$166,024+0.34%
Nov 20, 2023Nov 22, 2023Redmile Group, LLC
Dir
10%
BuyAugmedix, Inc.AUGX$4$6M+5.48%
Jun 29, 2023Jul 04, 2023Redmile Group, LLC
Dir
SellIgm Biosciences, Inc.IGMS$9.42$757,585-1.33%
Apr 20, 2023Apr 22, 2023Redmile Group, LLC
Dir
10%
BuyFate Therapeutics IncFATE$6.17$2M+2.06%
Oct 28, 2021Apr 22, 2023Redmile Group, LLC
Dir
10%
BuyAugmedix, Inc.AUGX$4$7M+20.72%
Apr 14, 2023Apr 18, 2023Redmile Group, LLC
Dir
10%
SellFate Therapeutics IncFATE$5.84$2M-2.30%
Oct 13, 2022Oct 18, 2022Redmile Group, LLC
10%
BuyZymeworks Inc.ZYME$5.03$153,435+0.50%
Nov 02, 2021Nov 05, 2021Redmile Group, LLC
10%
BuyEntrada Therapeutics, Inc.TRDA$20$20M+33.85%
Oct 28, 2021Nov 02, 2021Redmile Group, LLC
Dir
10%
BuyAugmedix, Inc.AUGX$4$7M+10.15%
Aug 10, 2021Aug 13, 2021Redmile Group, LLC
10%
BuyAdagio Therapeutics, Inc.ADGI$17$25M+30.24%
Jul 26, 2021Jul 29, 2021Redmile Group, LLC
Dir
BuyAbsci CorpABSI$16$30M+18.93%
Jun 21, 2021Jun 23, 2021Redmile Group, LLC
10%
BuyVerve Therapeutics, Inc.VERV$19$20M+35.16%
Dec 28, 2020Feb 16, 2021Redmile Group, LLC
10%
SellAprea Therapeutics, Inc.APRE$5.58$3M-22.04%
Jan 08, 2021Jan 12, 2021Redmile Group, LLC
Dir
10%
BuyFate Therapeutics IncFATE$85.5$28M+2.47%
Oct 14, 2020Oct 15, 2020Redmile Group, LLC
Dir
10%
BuyShattuck Labs, Inc.STTK$17.34$60M+37.98%
Oct 05, 2020Oct 07, 2020Redmile Group, LLC
Dir
10%
BuyAugmedix, Inc.AUGX$3$15M+28.16%
Sep 04, 2020Sep 09, 2020Redmile Group, LLC
Dir
10%
BuyIgm Biosciences, Inc.IGMS$50.52$7M+4.06%
Sep 01, 2020Sep 03, 2020Redmile Group, LLC
Dir
10%
BuyIgm Biosciences, Inc.IGMS$47.21$6M+4.00%
Jun 11, 2020Jun 18, 2020Redmile Group, LLC
Dir
10%
BuyFate Therapeutics IncFATE$28.31$40M+10.06%
Mar 27, 2020Apr 06, 2020Redmile Group, LLC
10%
BuyNeoleukin Therapeutics, Inc.NLTX$10.35$2M+4.59%
Oct 07, 2019Oct 09, 2019Redmile Group, LLC
10%
BuyAprea Therapeutics, Inc.APRE$15$6M+14.99%
Sep 16, 2019Sep 17, 2019Redmile Group, LLC
Dir
10%
BuyFate Therapeutics IncFATE$17.5$15M+7.10%
Feb 19, 2019Feb 21, 2019Redmile Group, LLC
10%
BuyXeris Pharmaceuticals IncXERS$10$6M+16.39%
Sep 25, 2018Sep 27, 2018Redmile Group, LLC
Dir
10%
BuyFate Therapeutics IncFATE$13.5$50M+26.34%